Page 5 - Wint Diggstown News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wint diggstown. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wint Diggstown Today - Breaking & Trending Today

Windtree Therapeutics (NASDAQ:WINT) Posts Quarterly Earnings Results, Misses Estimates By $2.51 EPS

Windtree Therapeutics (NASDAQ:WINT – Get Rating) announced its quarterly earnings results on Monday. The company reported ($13.01) earnings per share for the quarter, missing the consensus estimate of ($10.50) by ($2.51), MarketWatch Earnings reports. Windtree Therapeutics Stock Down 10.5 % NASDAQ WINT opened at $4.62 on Wednesday. The business’s 50-day moving average is $3.03 and […] ....

Windtree Therapeutics Inc , Envestnet Asset Management Inc , Windtree Therapeutics Company Profile , Renaissance Technologies , Millennium Management , Windtree Therapeutics , Get Rating , Marketwatch Earnings , Therapeutics Stock Down , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,

Windtree Therapeutics (NASDAQ:WINT) Issues Earnings Results, Misses Expectations By $2.51 EPS

Windtree Therapeutics (NASDAQ:WINT – Get Rating) announced its quarterly earnings data on Monday. The company reported ($13.01) earnings per share for the quarter, missing analysts’ consensus estimates of ($10.50) by ($2.51), MarketWatch Earnings reports. Windtree Therapeutics Trading Up 5.2 % NASDAQ WINT traded up $0.24 during trading on Wednesday, reaching $4.86. 6,872 shares of the […] ....

Windtree Therapeutics Inc , Renaissance Technologies , Millennium Management , Envestnet Asset Management Inc , Windtree Therapeutics Company Profile , Windtree Therapeutics , Get Rating , Marketwatch Earnings , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,

Windtree Therapeutics (NASDAQ:WINT) Releases Earnings Results, Misses Expectations By $2.51 EPS

Windtree Therapeutics (NASDAQ:WINT – Get Rating) issued its quarterly earnings data on Monday. The company reported ($13.01) earnings per share for the quarter, missing analysts’ consensus estimates of ($10.50) by ($2.51), MarketWatch Earnings reports. Windtree Therapeutics Trading Up 2.8 % Shares of NASDAQ WINT traded up $0.13 during trading on Wednesday, reaching $4.75. The stock […] ....

Millennium Management , Renaissance Technologies , Envestnet Asset Management Inc , Windtree Therapeutics Inc , Windtree Therapeutics , Get Rating , Marketwatch Earnings , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,

Windtree Therapeutics (NASDAQ:WINT) Issues Earnings Results

Windtree Therapeutics (NASDAQ:WINT – Get Rating) released its quarterly earnings results on Monday. The company reported ($13.01) earnings per share (EPS) for the quarter, missing the consensus estimate of ($10.50) by ($2.51), MarketWatch Earnings reports. Windtree Therapeutics Price Performance NASDAQ:WINT opened at $4.62 on Wednesday. The stock has a 50-day simple moving average of $3.03 […] ....

Envestnet Asset Management Inc , Windtree Therapeutics Inc , Renaissance Technologies , Millennium Management , Windtree Therapeutics , Get Rating , Marketwatch Earnings , Asset Management , Windtree Therapeutics Daily , Nasdaq Wint ,

Short Interest in Windtree Therapeutics, Inc. (NASDAQ:WINT) Drops By 53.0%

Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Rating) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 27,500 shares, a drop of 53.0% from the February 28th total of 58,500 shares. Approximately 4.9% of the company’s shares are short sold. Based […] ....

Windtree Therapeutics Company Profile , Millennium Management , Asset Management Corp , Windtree Therapeutics Inc , Virtu Financial , Envestnet Asset Management Inc , Renaissance Technologies , Windtree Therapeutics , Get Rating , Asset Management , Management Corp , Therapeutics Stock Down , Windtree Therapeutics Daily , Nasdaq Wint ,